37 results
8-K
EX-10.1
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
authorizations (collectively, “Governmental Authorizations”) from such federal, state or local government or governmental agency, department or body
8-K/A
EX-99.2
tl9fmycbxy
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
POS AM
EX-4.6
n786o2dcrl4qywbowh
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
POS AM
EX-4.5
cwk1ix3x1hr
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
424B3
38f6tdj ifm4
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
a2fjq
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
n5k562k np
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
EX-99.1
70ix2h32
24 May 23
Business combination disclosure
4:55pm
8-K
EX-99.1
vvri3cfu
24 May 23
Regulation FD Disclosure
4:53pm
425
1jj3unznr79n
24 May 23
Business combination disclosure
7:05am
425
n7fl1ka3
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
boweze8i1xo9901 molb
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
EX-1.2
ndcfh379vj
1 Nov 22
Shelf registration
4:51pm